G protein-coupled receptor heteromers as new targets for drug development (Q37778512)

23 August 2017

1 reference

title

G protein-coupled receptor heteromers as new targets for drug development (English)

1 reference

G protein-coupled receptor

23 August 2017

main subject

0 references

Enric I Canela

0 references

Rafael Franco

0 references

Antoni Cortés

1 reference

23 August 2017

Sergi Ferré

1 reference

23 August 2017

Gemma Navarro

1 reference

23 August 2017

Vicent Casadó

1 reference

23 August 2017

Josefa Mallol

1 reference

23 August 2017

Carme Lluís

1 reference

23 August 2017

publication date

1 January 2010

1 reference

Progress in Molecular Biology and Translational Science

23 August 2017

published in

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

41-52

1 reference

A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Building a new conceptual framework for receptor heteromers

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

The GDNF family: signalling, biological functions and therapeutic value

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Functional relevance of neurotransmitter receptor heteromers in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Allosteric modulation of heterodimeric G-protein-coupled receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers?

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

1 reference

7 January 2021

Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

G-protein-coupled receptor heterodimerization modulates receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

The histamine H3 receptor: from gene cloning to H3 receptor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Heterodimerization and surface localization of G protein coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

CXCR4-CCR5: a couple modulating T cell functions

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Resonance energy transfer approaches in molecular pharmacology and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Detection of heteromerization of more than two proteins by sequential BRET-FRET.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Light resonance energy transfer-based methods in the study of G protein-coupled receptor oligomerization

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Analysis of receptor oligomerization by FRAP microscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Bioinformatics and molecular modelling approaches to GPCR oligomerization.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Amazing stability of the arginine-phosphate electrostatic interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Dopamine D2 receptors form higher order oligomers at physiological expression levels

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Identification of a serotonin/glutamate receptor complex implicated in psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Dissociation of the opioid receptor mechanisms that control mechanical and heat pain

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2991002-8

7 January 2021

10.1016/S1877-1173(10)91002-8

Identifiers

DOI

1 reference

23 August 2017

1 reference